Epigenetic Regulation of Alcoholic Liver Fibrosis
Epigenetic Regulation of Alcoholic Liver Fibrosis
批准号:
9125700
负责人:
Tatiana Kisseleva
金额:
$32.0万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-01 至 2020-08-31
关键词:
ASCL1 geneAlcohol abuseAlcoholic Liver CirrhosisAlcoholsBioinformaticsCell Fate ControlChIP-seqCollaborationsDiseaseEZH2 geneEpigenetic ProcessEuchromatinEventExhibitsExonsExtracellular MatrixFibrosisGene ActivationGene TargetingGenesGeneticHealthHepatic FibrogenesisHepatic Stellate CellHeterochromatinHistone DeacetylaseIn VitroInternationalKnockout MiceKnowledgeLaboratoriesLiftingLiver FibrosisMLL geneMediatingMedicalMethodsMethyl-CpG-Binding Protein 2MethylationMethyltransferaseModalityModelingMolecularMusPathway interactionsPhenotypeReaderRepressionResearchResolutionRoleSourceStructureSystemTestingTherapeuticUp-RegulationVitamin AWild Type MouseWorkbasecombinatorialepigenetic memoryepigenetic regulationgene inductionhistone methyltransferasein vivoknock-downliver transplantationloss of functionmouse modelnotch proteinnovelpreventproblem drinkerpromotersmall hairpin RNAtherapeutic targettranscriptome sequencingtransdifferentiation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Alcoholic cirrhosis is the most prevalent and devastating medical consequence of alcohol abuse with no efficacious treatment except for liver transplantation. Myofibroblastic transdifferentiation of hepatic stellate cells (HSCs) commonly called HSC activation, constitutes a major mechanistic event in alcoholic liver fibrosis. We hypothesize epigenetic regulation dictates this cell fate regulation and serves as a most plausible therapeutic target. In support of this hypothesis, our research conducted to date revealed the methyl-CpG binding protein MeCP2 orchestrates epigenetic HSC activation via: 1) repression of the HSC quiescence gene Ppar-¿ via recruitment of HP1¿ co-repressor and EZH2-mediated H3K27 di- or tri-methylation; 2) up regulation of ASH1 histone methyltransferase which in turn induces fibrogenic genes such as Col1a1, aSma, Timp1, Tgf-¿1 via H3K4 methylation. [We also demonstrated conspicuous upregulation of another H3K4 methyltrasferase, MLL1 and co-enrichment of MLL1 and H3K4me3 in a uniquely segregated set of genes with potential activation roles by combinatorial ChIP-seq and RNA-seq analyses.] Via international collaboration of three leading laboratories with complementary expertise, we propose to extend these novel findings to further define the causal roles of MeCP2, ASH1, and MLL1 in HSC activation and alcoholic liver fibrosis by pursuing the following specific aims: [1) to
determine whether inducible and activated HSC- targeted MeCP2 deficiency prevents the progression of alcoholic liver fibrosis by using mice harboring MeCP2f/y and Col1a1-CreERT; 2) to discover how MeCP2 and the H3K4 HAT ASH1 and MLL1 render epigenetic activation of HSCs in alcoholic liver fibrogenesis; 3) to determine whether there is epigenetic control of HSC phenotype reversion and whether "epigenetic memory" is causally associated with increased re-activation propensity of iHSCs by using Col1a2-CreERT:Rosa26flox-stop-flox-YFP mice and FACS-based isolation of HSCs at the peak of alcoholic liver fibrosis and after resolution from fibrosis. ]
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of IL-17 signaling in alcohol-induced HCC
-
批准号:10463697
-
项目类别:
-
资助金额:$46.45万
-
财政年份:2021
-
负责人:Tatiana Kisseleva
-
依托单位:
The role of IL-17 signaling in alcohol-induced HCC
-
批准号:10299157
-
项目类别:
-
资助金额:$46.45万
-
财政年份:2021
-
负责人:Tatiana Kisseleva
-
依托单位:
Novel IL-23 inhibitor for the treatment of alcohol associated liver disease
-
批准号:10482350
-
项目类别:
-
资助金额:$69.95万
-
财政年份:2020
-
负责人:Tatiana Kisseleva
-
依托单位:
Novel IL-23 inhibitor for the treatment of alcohol associated liver disease
-
批准号:10266186
-
项目类别:
-
资助金额:$78.14万
-
财政年份:2020
-
负责人:Tatiana Kisseleva
-
依托单位:
Preclinical Models Core
-
批准号:10617220
-
项目类别:
-
资助金额:$26.43万
-
财政年份:2019
-
负责人:Tatiana Kisseleva
-
依托单位:
Fibrocytes regulate liver fibrosis
-
批准号:9218867
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2017
-
负责人:Tatiana Kisseleva
-
依托单位:
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis
-
批准号:10441586
-
项目类别:
-
资助金额:$48.66万
-
财政年份:2014
-
负责人:Tatiana Kisseleva
-
依托单位:
Inactivation of Hepatic Stellate Cells During Reversal of Liver Fibrosis
-
批准号:8694267
-
项目类别:
-
资助金额:$33.71万
-
财政年份:2014
-
负责人:Tatiana Kisseleva
-
依托单位:
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis
-
批准号:10312314
-
项目类别:
-
资助金额:$48.66万
-
财政年份:2014
-
负责人:Tatiana Kisseleva
-
依托单位:
Epigenetics of human Hepatic Stellate Cells (HSCs) in NASH
-
批准号:10367096
-
项目类别:
-
资助金额:$62.58万
-
财政年份:2014
-
负责人:Tatiana Kisseleva
-
依托单位:
Inactivation of Hepatic Stellate Cells During Reversal of Liver Fibrosis
-
批准号:9271180
-
项目类别:
-
资助金额:$33.71万
-
财政年份:2014
-
负责人:Tatiana Kisseleva
-
依托单位:
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis
-
批准号:10576954
-
项目类别:
-
资助金额:$48.66万
-
财政年份:2014
-
负责人:Tatiana Kisseleva
-
依托单位:
Inactivation of Hepatic Stellate Cells During Reversal of Liver Fibrosis
-
批准号:8845551
-
项目类别:
-
资助金额:$33.71万
-
财政年份:2014
-
负责人:Tatiana Kisseleva
-
依托单位:
Inactivation of Hepatic Stellate Cells During Reversal of Liver Fibrosis
-
批准号:9068088
-
项目类别:
-
资助金额:$33.71万
-
财政年份:2014
-
负责人:Tatiana Kisseleva
-
依托单位:
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis
-
批准号:8816891
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2014
-
负责人:Tatiana Kisseleva
-
依托单位:
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis
-
批准号:9335824
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2014
-
负责人:Tatiana Kisseleva
-
依托单位:
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis
-
批准号:9127227
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2014
-
负责人:Tatiana Kisseleva
-
依托单位:
The Role of Fibrocytes in Liver Fibrosis
-
批准号:8545652
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2012
-
负责人:Tatiana Kisseleva
-
依托单位:
海外基金